12:00 AM
May 28, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Arrowhead preclinical data

In a mouse model of HBV infection, single injections of hepatocyte-targeted anti-HBV siRNA DPCs delivered using Arrowhead's Dynamic Polyconjugate (DPC) delivery technology resulted in a...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >